Search research articles
Contact Us
Filters
Showing results (171-180 of 202) with videos related to
Page
of 21
Sort By:
ACR Open Rheumatology
|
July 1, 2024
Multi-Autoantibody Testing Identifies Expansion of Reactivity to Targeted Antigens Before a Diagnosis of Rheumatoid Arthritis
Salina H Goff, Dylan T Bergstedt, Marie L Feser, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 2017
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome
Marisa Benagiano, Maria Gerosa, Jacopo Romagnoli, et al.
Frontiers in Immunology
|
March 21, 2019
Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study
Savino Sciascia, Massimo Radin, Irene Cecchi, et al.
Lupus Science & Medicine
|
May 29, 2026
Clinical utility of a multianalyte lupus risk score incorporating cell-bound complement activation products: a systematic evaluation
Vasileios C Kyttaris, Michelle A Petri, Daniel J Wallace, et al.
Rheumatology (Oxford, England)
|
March 20, 2021
Anti-RNPC-3 antibody predicts poor prognosis in patients with interstitial lung disease associated to systemic sclerosis
Eduardo Luis Callejas-Moraga, Alfredo Guillén-Del-Castillo, Janire Perurena-Prieto, et al.
Diagnostics (Basel, Switzerland)
|
April 13, 2023
Anti-U11/U12 Antibodies as a Rare but Important Biomarker in Patients with Systemic Sclerosis: A Narrative Review
Marvin J Fritzler, Chelsea Bentow, Lorenzo Beretta, et al.
Plos One
|
November 15, 2014
PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC)
Laura M Stinton, Chelsea Bentow, Michael Mahler, et al.
Arthritis Research & Therapy
|
December 7, 2019
Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs
Emma C de Moel, Jürgen Rech, Michael Mahler, et al.
Journal of Medical Virology
|
August 8, 2022
Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID-19 severity: An Italian study
Maria Infantino, Mariangela Manfredi, Maria Grazia Alessio, et al.
Clinical and Vaccine Immunology : CVI
|
January 24, 2006
International multicenter evaluation of autoantibodies to ribosomal P proteins
Michael Mahler, Kai Kessenbrock, Magdalena Szmyrka, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 202) with videos related to
Sort By:
Page
of 21
ACR Open Rheumatology
|
July 1, 2024
Multi-Autoantibody Testing Identifies Expansion of Reactivity to Targeted Antigens Before a Diagnosis of Rheumatoid Arthritis
Salina H Goff, Dylan T Bergstedt, Marie L Feser, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 2017
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome
Marisa Benagiano, Maria Gerosa, Jacopo Romagnoli, et al.
Frontiers in Immunology
|
March 21, 2019
Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study
Savino Sciascia, Massimo Radin, Irene Cecchi, et al.
Lupus Science & Medicine
|
May 29, 2026
Clinical utility of a multianalyte lupus risk score incorporating cell-bound complement activation products: a systematic evaluation
Vasileios C Kyttaris, Michelle A Petri, Daniel J Wallace, et al.
Rheumatology (Oxford, England)
|
March 20, 2021
Anti-RNPC-3 antibody predicts poor prognosis in patients with interstitial lung disease associated to systemic sclerosis
Eduardo Luis Callejas-Moraga, Alfredo Guillén-Del-Castillo, Janire Perurena-Prieto, et al.
Diagnostics (Basel, Switzerland)
|
April 13, 2023
Anti-U11/U12 Antibodies as a Rare but Important Biomarker in Patients with Systemic Sclerosis: A Narrative Review
Marvin J Fritzler, Chelsea Bentow, Lorenzo Beretta, et al.
Plos One
|
November 15, 2014
PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC)
Laura M Stinton, Chelsea Bentow, Michael Mahler, et al.
Arthritis Research & Therapy
|
December 7, 2019
Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs
Emma C de Moel, Jürgen Rech, Michael Mahler, et al.
Journal of Medical Virology
|
August 8, 2022
Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID-19 severity: An Italian study
Maria Infantino, Mariangela Manfredi, Maria Grazia Alessio, et al.
Clinical and Vaccine Immunology : CVI
|
January 24, 2006
International multicenter evaluation of autoantibodies to ribosomal P proteins
Michael Mahler, Kai Kessenbrock, Magdalena Szmyrka, et al.
Page
of 21